25 related articles for article (PubMed ID: 22577174)
1. Cytokine release assays for the prediction of therapeutic mAb safety in first-in man trials--Whole blood cytokine release assays are poorly predictive for TGN1412 cytokine storm.
Vessillier S; Eastwood D; Fox B; Sathish J; Sethu S; Dougall T; Thorpe SJ; Thorpe R; Stebbings R
J Immunol Methods; 2015 Sep; 424():43-52. PubMed ID: 25960173
[TBL] [Abstract][Full Text] [Related]
2. Discovery of ICOS-Targeted Small Molecules Using Pharmacophore-Based Screening.
Calvo-Barreiro L; Talagayev V; Pach S; Abdel-Rahman SA; Wolber G; Gabr MT
ChemMedChem; 2023 Dec; 18(23):e202300305. PubMed ID: 37845178
[TBL] [Abstract][Full Text] [Related]
3. Myelopoiesis of acute inflammation: lessons from TGN1412-induced cytokine storm.
Panoskaltsis N; McCarthy NE; Knight SC
Cancer Immunol Immunother; 2021 Apr; 70(4):1155-1160. PubMed ID: 32862238
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal costimulatory molecules control the activation of mucosal type 3 innate lymphoid cells during engagement with B cells.
Lv X; Zhu S; Wu J; Shi J; Wei Q; Li T; Yang N; Liu C; Qi L; Zang G; Cheng H; Yang Z; Jin C; Wang Y; Cui J; Ueno H; Liu YJ; Chen J
Cell Mol Immunol; 2023 Jul; 20(7):808-819. PubMed ID: 37225838
[TBL] [Abstract][Full Text] [Related]
5. Identification of Novel Modalities Through Bibliometric Analysis for Timely Development of Regulatory Guidance: A Case Study of T Cell Immunity.
Fukaya-Shiba A; Otsuka K; Sasaki H; Shikano M; Wakao R
Front Med (Lausanne); 2021; 8():756870. PubMed ID: 34708061
[No Abstract] [Full Text] [Related]
6. Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.
Tomić S; Đokić J; Stevanović D; Ilić N; Gruden-Movsesijan A; Dinić M; Radojević D; Bekić M; Mitrović N; Tomašević R; Mikić D; Stojanović D; Čolić M
Front Immunol; 2021; 12():614599. PubMed ID: 33692788
[TBL] [Abstract][Full Text] [Related]
7. Anti-Tumor Necrosis Factor α Therapeutics Differentially Affect
Arens K; Filippis C; Kleinfelder H; Goetzee A; Reichmann G; Crauwels P; Waibler Z; Bagola K; van Zandbergen G
Front Immunol; 2018; 9():1772. PubMed ID: 30108591
[TBL] [Abstract][Full Text] [Related]
8. TGN1412 Induces Lymphopenia and Human Cytokine Release in a Humanized Mouse Model.
Weißmüller S; Kronhart S; Kreuz D; Schnierle B; Kalinke U; Kirberg J; Hanschmann KM; Waibler Z
PLoS One; 2016; 11(3):e0149093. PubMed ID: 26959227
[TBL] [Abstract][Full Text] [Related]
9. High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus.
Scheuplein VA; Seifried J; Malczyk AH; Miller L; Höcker L; Vergara-Alert J; Dolnik O; Zielecki F; Becker B; Spreitzer I; König R; Becker S; Waibler Z; Mühlebach MD
J Virol; 2015 Apr; 89(7):3859-69. PubMed ID: 25609809
[TBL] [Abstract][Full Text] [Related]
10. Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28.
Poirier N; Mary C; Le Bas-Bernardet S; Daguin V; Belarif L; Chevalier M; Hervouet J; Minault D; Ville S; Charpy V; Blancho G; Vanhove B
MAbs; 2014; 6(3):697-707. PubMed ID: 24598534
[TBL] [Abstract][Full Text] [Related]
11. Severity of the TGN1412 trial disaster cytokine storm correlated with IL-2 release.
Eastwood D; Bird C; Dilger P; Hockley J; Findlay L; Poole S; Thorpe SJ; Wadhwa M; Thorpe R; Stebbings R
Br J Clin Pharmacol; 2013 Aug; 76(2):299-315. PubMed ID: 23701319
[TBL] [Abstract][Full Text] [Related]
12. Antibody C region influences TGN1412-like functional activity in vitro.
Ball C; Fox B; Hufton S; Sharp G; Poole S; Stebbings R; Eastwood D; Findlay L; Parren PW; Thorpe R; Bristow A; Thorpe SJ
J Immunol; 2012 Dec; 189(12):5831-40. PubMed ID: 23150712
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cells co-stimulate peripheral blood mononuclear cell responses to monoclonal antibody TGN1412 in culture.
Findlay L; Sharp G; Fox B; Ball C; Robinson CJ; Bird C; Stebbings R; Eastwood D; Wadhwa M; Poole S; Thorpe R; Thorpe SJ
Cytokine; 2011 Jul; 55(1):141-51. PubMed ID: 21493088
[TBL] [Abstract][Full Text] [Related]
14. Human Fcγ receptors compete for TGN1412 binding that determines the antibody's effector function.
Dudek S; Weißmüller S; Anzaghe M; Miller L; Sterr S; Hoffmann K; Hengel H; Waibler Z
Eur J Immunol; 2019 Jul; 49(7):1117-1126. PubMed ID: 31002172
[TBL] [Abstract][Full Text] [Related]
15. LICOS, a primordial costimulatory ligand?
Brodie D; Collins AV; Iaboni A; Fennelly JA; Sparks LM; Xu XN; van der Merwe PA; Davis SJ
Curr Biol; 2000 Mar; 10(6):333-6. PubMed ID: 10744980
[TBL] [Abstract][Full Text] [Related]
16. ICOS-LICOS interaction is critically involved in TGN1412-mediated T-cell activation.
Weissmüller S; Semmler LY; Kalinke U; Christians S; Müller-Berghaus J; Waibler Z
Blood; 2012 Jun; 119(26):6268-77. PubMed ID: 22577174
[TBL] [Abstract][Full Text] [Related]
17. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus.
Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
